DERMAPHARM HLDG.
DMP.XETRA | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Dermapharm Holding SE is a Germany-based pharmaceutical company. It specializes in the development, manufacture and distribution of branded pharmaceuticals and other healthcare products. The company operates through two segments: Branded Pharmaceuticals and 'Other Products'. The Branded Pharmaceutic...Show More
Better Health for All
-20
Dermapharm Holding SE's core business is focused on health improvement, manufacturing branded pharmaceuticals, OTC medications, medical devices, food supplements, cosmetics, and herbal extracts.
1
The company is a market leader in prescription dermatologics, prescription vitamins, catheter lubricants, and pollen extract for prostate conditions.
2
It also produces dronabinol for severe illnesses, treating over 80,000 patients in Germany.
3
The company reports no revenue from products with negative health outcomes.
4
Its product complaint rate declined to 0.002% in 2023 and 0.003% in 2022, with no recalls or adverse events mentioned for Sonoma products.
5
Dermapharm's parallel import business, axicorp, exploits price differences within the EU to benefit Germany’s statutory health insurance system, and the company targets developing compounds using off-patent active pharmaceutical ingredients.
6
The company's R&D expenses were $1.871 million in 2024, representing 14.69% of its $12.735 million revenue for Sonoma Pharmaceuticals, and approximately 3% of revenue from branded pharmaceuticals for Dermapharm in FY2023.
7
Dermapharm has a centralized IT security department based on ISO 27001 requirements and complies with HIPAA.
8
During the COVID-19 pandemic, Nanocyn® Disinfectant & Sanitizer received approval for use against the virus in Australia and Canada.
9
The company offers health and fitness programs and conducts mental health surveys for employees, and company physicians are a point of contact for suspected psychological or addiction problems.
10
Dermapharm adheres to Good Clinical Practice (GCP) for clinical trials, ensuring they are ethically sound and transparent.
11
Fair Money & Economic Opportunity
0
Dermapharm Holding SE is a pharmaceutical company specializing in branded pharmaceuticals and other healthcare products.
1
The ethical value 'Fair Money & Economic Opportunity' is designed to assess financial institutions that lend, insure, move, or store money. The provided articles focus on Dermapharm's financial performance, operations, and general compliance within the pharmaceutical industry. There is no evidence in the articles that the company offers any lending, deposit, or other financial services to consumers or businesses.
2
Therefore, none of the KPIs under this value are applicable or have relevant data, and all are omitted.
Fair Pay & Worker Respect
0
No specific, quantitative data was found across the provided articles for any of the Key Performance Indicators related to Fair Pay & Worker Respect. The articles primarily focus on financial performance, acquisitions, and general compliance policies, without disclosing metrics such as living wage coverage, CEO-median pay ratio, collective bargaining share, safety incident rates, pay equity ratios, worker engagement scores, employee turnover rates, labor violation incidents, insecure contract share, or health insurance coverage.
1
While CEO compensation is mentioned, the median employee compensation for Dermapharm is not provided, preventing calculation of the CEO-median pay ratio.
2
Fair Trade & Ethical Sourcing
0
Dermapharm's reports explicitly state a lack of quantitative data for several metrics relevant to Fair Trade & Ethical Sourcing
1
. There is no specific data provided for fair trade certification share, audit frequency for tier-1 suppliers, substantiated forced or child labor incidents, traceability coverage, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend
2
. While the company outlines a commitment to human rights and environmental due diligence, including a risk management system for suppliers and a complaints procedure
3
, and aims to improve data for transparent supply chains
4
, these are policy statements or future goals rather than current quantifiable evidence for the KPIs.
Honest & Fair Business
0
Dermapharm has a digital whistleblower system that allows for anonymous and confidential reports, protects whistleblowers from reprisals, and ensures reports are investigated immediately and in detail according to a standardized process.
1
The company has not mentioned any financial restatements in the past five years.
2
The Supervisory Board, which also acts as the audit committee, met five times in 2024 with 100% attendance, and the auditor was present at one meeting to report on material findings.
3
However, the Group's non-financial report was not subjected to a substantive audit by the external auditor.
4
The company reported no incidents or actual impacts in 2024 that violated good corporate governance principles.
5
While the company states that every report of potential misconduct is investigated immediately, no specific median resolution time for ethics complaints is provided.
6
The company reported no conflicts of interest in the past financial year.
7
Dermapharm has a binding anti-corruption policy that prohibits bribery and corruption, and it is a member of the AKG, an association promoting compliance in the pharmaceuticals industry.
8
The company's non-financial report was assessed by the Supervisory Board but not substantively audited by the external auditor, though internal investigations may involve an external law firm depending on severity.
9
Kind to Animals
30
Dermapharm does not conduct animal testing, and did not do so in 2020.
1
The company's policy, as stated in its Supplier Code of Conduct (2024) and 2020 report, indicates that animal testing may be carried out only if unavoidable or required by authorities and in accordance with regulations.
2
For its animal agriculture ethics, organic waste generated during production at its subsidiary Euromed is used as feed for livestock.
3
Additionally, the company is certified to produce products that meet the criteria for certification from The Vegan Society.
4
No War, No Weapons
0
No evidence available to assess DERMAPHARM HLDG on No War, No Weapons.
Planet-Friendly Business
-20
In 2024, Dermapharm Holding SE sourced 2.52% of its total operational energy consumption from renewable sources, primarily photovoltaic yield.
1
The company's fresh water usage in 2024 was 278,480 m³, with a revenue of EUR 1,180.8 million, resulting in 235.84 m³ per EUR million.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Respect for Cultures & Communities. The articles explicitly state a lack of information regarding formal partnerships with indigenous or local community groups, revenue reinvested in local community development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, grievance mechanisms for community concerns, community complaint resolution times, FPIC participation rates, community governance inclusion, cultural preservation investment, local procurement, indigenous supplier counts, cultural site protection, social license to operate, charitable giving to cultural heritage organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion.
1
Safe & Smart Tech
-30
In 2023, 1,265 out of 3,497 employees (approximately 36.17%) participated in the e-Campus program, which includes information security training.
1
Regular training on product and service safety is provided to all employees every three years.
2
The company uses TLSv1.0, TLSv1.1, TLSv1.2, and TLSv1.3 encryption algorithms and cipher suites.
3
Dermapharm has an IT security and authorization concept, uses redundant data processing centers, Group-wide anti-virus programs, and performs regular software and hardware maintenance and routine backups of business-critical data.
4
As an operator of critical national infrastructure, its systems are subject to external cybersecurity audits every other year.
5
The company states compliance with GDPR, BDSG, TMG, and other regulations, and was not aware of any material compliance violations in 2023.
6
IP addresses in server log files are stored for a maximum of 180 days, and user-related data for Google Analytics is automatically deleted after 14 months.
7
Users have control over cookies and newsletter subscriptions.
8
DocCheck Log-In is used for verifying professional affiliation.
9
The company monitors for offenses against HPKP, CSP, DDOS, and access restrictions of server directories.
10
Zero Waste & Sustainable Products
-30
Dermapharm's Spanish subsidiary, Euromed, processes organic waste from herbal extract production for energy generation, composting, or livestock feed, and recycles fruit extraction residue into natural dyes.
1
The company reported no waste disposal violations in the past three years.
2
Hazardous waste management is compliant with statutory regulations, with 154 tonnes of hazardous waste produced in 2024.
3
Energy audits have been certified by an accredited engineering firm since 2015, in accordance with DIN EN1642, and waste audits are mentioned as regular.
4